Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Feb 06 2026

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 06, 2026, titled "Alembic Pharmaceuticals Limited announces USFDA Final Approval for Carbidopa, Levodopa and Entacapone Tablets.".

Alembic Pharmaceuticals Limited on 6ix

In the deck

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases